Jaundice developing in a patient with hepatitis C4 months after liver transplantation

Hepatology. 2009 Feb;49(2):695-6. doi: 10.1002/hep.22785.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Fatal Outcome
  • Hepatitis C / drug therapy
  • Hepatitis C / surgery*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Jaundice / diagnosis
  • Liver Cirrhosis / surgery
  • Liver Cirrhosis / virology
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / immunology
  • Male
  • Middle Aged
  • Polyethylene Glycols / therapeutic use
  • Postoperative Complications / diagnosis*
  • Recombinant Proteins
  • Ribavirin / therapeutic use
  • Tacrolimus / therapeutic use

Substances

  • Antiviral Agents
  • Immunosuppressive Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a
  • Tacrolimus